{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:44:00Z","timestamp":1793817840894,"version":"4.6.1"},"reference-count":203,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neuroscience.2025.10.050","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:25:47Z","timestamp":1761870347000},"page":"170-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"590","author":[{"family":"Vanya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajal","family":"Bagri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.neuroscience.2025.10.050_b0005","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/nn.2433","article-title":"Amyloid-\u0392 as a positive endogenous regulator of release probability at hippocampal synapses","volume":"12","author":"Abramov","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0010","doi-asserted-by":"crossref","unstructured":"Abrego-Guandique, D. M., Saraceno, G. F., Cannataro, R., Manzzo de Burnside, M., Caroleo, M. C., & Cione, E. (2024). Apolipoprotein E and Alzheimer\u2019s Disease in Italian Population: Systematic Review and Meta-Analysis. In Brain Sciences (Vol. 14, Issue 9). Multidisciplinary Digital Publishing Institute (MDPI). DOI: 10.3390\/brainsci14090908.","DOI":"10.3390\/brainsci14090908"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0015","doi-asserted-by":"crossref","unstructured":"Abyadeh, M., Gupta, V., Chitranshi, N., Gupta, V., Wu, Y., Saks, D., Wander Wall, R., Fitzhenry, M. J., Basavarajappa, D., You, Y., Salekdeh, G. H., Haynes, P. a., Graham, S. L., & Mirzaei, M. (2021). Mitochondrial dysfunction in Alzheimer\u2019s disease - a proteomics perspective. In Expert Review of Proteomics (Vol. 18, Issue 4, pp. 295\u2013304). Taylor and Francis Ltd. DOI: 10.1080\/14789450.2021.1918550.","DOI":"10.1080\/14789450.2021.1918550"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0020","doi-asserted-by":"crossref","unstructured":"Ahmed, H., Wang, Y., Griffiths, W. J., Levey, A. I., Pikuleva, I., Liang, S. H., & Haider, A. (2024). Brain cholesterol and Alzheimer\u2019s disease: Challenges and opportunities in probe and drug development. In Brain (Vol. 147, Issue 5, pp. 1622\u20131635). Oxford University Press. DOI: 10.1093\/brain\/awae028.","DOI":"10.1093\/brain\/awae028"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0025","doi-asserted-by":"crossref","unstructured":"Aikawa, T., Holm, M. L., & Kanekiyo, T. (2018). ABCA7 and pathogenic pathways of Alzheimer\u2019s disease. In Brain Sciences (Vol. 8, Issue 2). MDPI AG. DOI: 10.3390\/brainsci8020027.","DOI":"10.3390\/brainsci8020027"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0030","doi-asserted-by":"crossref","unstructured":"Aizenstein, H. J., & Klunk, W. E. (2015). Where is hippocampal activity in the cascade of Alzheimer\u2019s disease biomarkers? In Brain (Vol. 138, Issue 4, pp. 831\u2013833). Oxford University Press. DOI: 10.1093\/brain\/awv001.","DOI":"10.1093\/brain\/awv001"},{"issue":"18","key":"10.1016\/j.neuroscience.2025.10.050_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810572","article-title":"Glial Cell-Mediated Neuroinflammation in Alzheimer\u2019s Disease","volume":"23","author":"Al-Ghraiybah","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0045","doi-asserted-by":"crossref","unstructured":"Al-kuraishy, H. M., Sulaiman, G. M., Mohammed, H. A., Dawood, R. A., Albuhadily, A. K., Al-Gareeb, A. I., Abomughaid, M. M., & Klionsky, D. J. (2025). Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus. In Neuropsychopharmacology Reports (Vol. 45, Issue 1). John Wiley and Sons Inc. DOI: 10.1002\/npr2.12525.","DOI":"10.1002\/npr2.12525"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0050","doi-asserted-by":"crossref","unstructured":"Almeida, Z. L., Vaz, D. C., & Brito, R. M. M. (2025). Morphological and Molecular Profiling of Amyloid-\u03b2 Species in Alzheimer\u2019s Pathogenesis. Mol. Neurobiol. (Vol. 62, Issue 4, pp. 4391\u20134419). Springer. Doi: 10.1007\/s12035-024-04543-4.","DOI":"10.1007\/s12035-024-04543-4"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0055","doi-asserted-by":"crossref","unstructured":"Alquezar, C., Arya, S., & Kao, A. W. (2021). Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation. Front. Neurol. (Vol. 11). Frontiers Media S.A. DOI: 10.3389\/fneur.2020.595532.","DOI":"10.3389\/fneur.2020.595532"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.10.050_b0060","doi-asserted-by":"crossref","first-page":"833.e1","DOI":"10.1016\/j.neurobiolaging.2011.08.001","article-title":"Interaction between NH2-tau fragment and A\u03b2 in Alzheimer\u2019s disease mitochondria contributes to the synaptic deterioration","volume":"33","author":"Amadoro","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"22","key":"10.1016\/j.neuroscience.2025.10.050_b0065","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1523\/JNEUROSCI.4637-04.2005","article-title":"Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms","volume":"25","author":"Andorfer","year":"2005","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.050_b0070","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","article-title":"Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms","volume":"86","author":"Andorfer","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0075","doi-asserted-by":"crossref","unstructured":"Andres-Alonso, M., Kreutz, M. R., & Karpova, A. (2021). Autophagy and the endolysosomal system in presynaptic function. Cellul. Molecul. Life Sci. (Vol. 78, Issue 6, pp. 2621\u20132639). Springer Science and Business Media Deutschland GmbH. DOI: 10.1007\/s00018-020-03722-5.","DOI":"10.1007\/s00018-020-03722-5"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0080","doi-asserted-by":"crossref","unstructured":"Andrews, S. J., Renton, A. E., Fulton-Howard, B., Podlesny-Drabiniok, A., Marcora, E., & Goate, A. M. (2023). The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions. eBioMedicine (Vol. 90). Elsevier B.V. DOI: 10.1016\/j.ebiom.2023.104511.","DOI":"10.1016\/j.ebiom.2023.104511"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0085","doi-asserted-by":"crossref","unstructured":"Angelopoulou, E., Bougea, A., Hatzimanolis, A., Scarmeas, N., & Papageorgiou, S. G. (2024). Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology. In Cells (Vol. 13, Issue 13). Multidisciplinary Digital Publishing Institute (MDPI). DOI: 10.3390\/cells13131164.","DOI":"10.3390\/cells13131164"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0090","doi-asserted-by":"crossref","unstructured":"Armstrong, R. A. (2019). Risk factors for Alzheimer\u2019s disease. Folia Neuropathol. (Vol. 57, Issue 2, pp. 87\u2013105). Termedia Publishing House Ltd. Doi: 10.5114\/fn.2019.85929.","DOI":"10.5114\/fn.2019.85929"},{"issue":"10","key":"10.1016\/j.neuroscience.2025.10.050_b0095","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.bbabio.2008.07.004","article-title":"A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator","volume":"1777","author":"Atlante","year":"2008","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0105","doi-asserted-by":"crossref","unstructured":"Azargoonjahromi, A. (2024). The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease states. Molecul. Brain (Vol. 17, Issue 1). BioMed Central Ltd. Doi: 10.1186\/s13041-024-01118-1.","DOI":"10.1186\/s13041-024-01118-1"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0110","doi-asserted-by":"crossref","unstructured":"Babcock, K. R., Page, J. S., Fallon, J. R., & Webb, A. E. (2021). Adult Hippocampal Neurogenesis in Aging and Alzheimer\u2019s Disease. Stem Cell Reports (Vol. 16, Issue 4, pp. 681\u2013693). Cell Press. Doi: 10.1016\/j.stemcr.2021.01.019.","DOI":"10.1016\/j.stemcr.2021.01.019"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0115","doi-asserted-by":"crossref","unstructured":"Bai, R., Guo, J., Ye, X. Y., Xie, Y., & Xie, T. (2022). Oxidative stress: The core pathogenesis and mechanism of Alzheimer\u2019s disease. Age. Res. Rev. (Vol. 77). Elsevier Ireland Ltd. Doi: 10.1016\/j.arr.2022.101619.","DOI":"10.1016\/j.arr.2022.101619"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0120","doi-asserted-by":"crossref","unstructured":"Bakulski, K. M., Seo, Y. A., Hickman, R. C., Brandt, D., Vadari, H. S., Hu, H., & Park, S. K. (2020). Heavy Metals Exposure and Alzheimer\u2019s Disease and Related Dementias. J. Alzheim. Dis. (Vol. 76, Issue 4, pp. 1215\u20131242). IOS Press BV. DOI: 10.3233\/JAD-200282.","DOI":"10.3233\/JAD-200282"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.10.050_b0125","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.bpj.2013.04.056","article-title":"Differences in \u03b2-strand populations of monomeric A\u03b240 and A\u03b242","volume":"104","author":"Ball","year":"2013","journal-title":"Biophys. J ."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0130","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-020-02211-x","article-title":"The interplay of ABC transporters in A\u03b2 translocation and cholesterol metabolism: implicating their roles in Alzheimer\u2019s disease","author":"Behl","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0135","doi-asserted-by":"crossref","unstructured":"Belaidi, A. A., Bush, A. I., & Ayton, S. (2025). Apolipoprotein E in Alzheimer\u2019s disease: molecular insights and therapeutic opportunities. Molecul. Neurodegenerat. (Vol. 20, Issue 1). BioMed Central Ltd. DOI: 10.1186\/s13024-025-00843-y.","DOI":"10.1186\/s13024-025-00843-y"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0140","doi-asserted-by":"crossref","unstructured":"Bird, T. D. (2008). Genetic aspects of Alzheimer disease. In Genet. Med. (Vol. 10, Issue 4, pp. 231\u2013239). DOI: 10.1097\/GIM.0b013e31816b64dc.","DOI":"10.1097\/GIM.0b013e31816b64dc"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0145","doi-asserted-by":"crossref","unstructured":"Boutajangout, A., Sigurdsson, E. M., & Krishnamurthy, P. K. (2011). Tau as a Therapeutic Target for Alzheimer\u2019s Disease.","DOI":"10.2174\/156720511796717195"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.050_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020313","article-title":"The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells","volume":"13","author":"Cai","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0160","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-024-00702-2","article-title":"Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid \u03b2 aggregates in vivo in a mouse model of Alzheimer\u2019s disease","volume":"19","author":"Calvo-Rodriguez","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0170","doi-asserted-by":"crossref","unstructured":"Carmona, S., Zahs, K., Wu, E., Dakin, K., Bras, J., & Guerreiro, R. (2018). The role of TREM2 in Alzheimer\u2019s disease and other neurodegenerative disorders. Lancet Neurol. (Vol. 17, Issue 8, pp. 721\u2013730). Lancet Publishing Group. DOI: 10.1016\/S1474-4422(18)30232-1.","DOI":"10.1016\/S1474-4422(18)30232-1"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0175","doi-asserted-by":"crossref","unstructured":"Chai, A. B., Lam, H. H. J., Kockx, M., & Gelissen, I. C. (2021). Apolipoprotein E isoform-dependent effects on the processing of Alzheimer\u2019s amyloid-\u03b2. In Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids (Vol. 1866, Issue 9). Elsevier B.V. DOI: 10.1016\/j.bbalip.2021.158980.","DOI":"10.1016\/j.bbalip.2021.158980"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.10.050_b0180","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mp.2013.1","article-title":"Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology","volume":"18","author":"Chapuis","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0185","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-021-00426-7","article-title":"Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer\u2019s disease neuropathology","volume":"16","author":"Chen","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0190","doi-asserted-by":"crossref","unstructured":"Chen, G. F., Xu, T. H., Yan, Y., Zhou, Y. R., Jiang, Y., Melcher, K., & Xu, H. E. (2017). Amyloid beta: Structure, biology and structure-based therapeutic development. In Acta Pharmacologica Sinica (Vol. 38, Issue 9, pp. 1205\u20131235). Nature Publishing Group. DOI: 10.1038\/aps.2017.28.","DOI":"10.1038\/aps.2017.28"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0195","doi-asserted-by":"crossref","unstructured":"Chen, Z., Yuan, Z., Yang, S., Zhu, Y., Xue, M., Zhang, J., & Leng, L. (2023). Brain Energy Metabolism: Astrocytes in Neurodegenerative Diseases. CNS Neurosci. Therapeut. (Vol. 29, Issue 1, pp. 24\u201336). John Wiley and Sons Inc. DOI: 10.1111\/cns.13982.","DOI":"10.1111\/cns.13982"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0200","doi-asserted-by":"crossref","unstructured":"Cho, S., Lee, H., & Seo, J. (2021). Impact of Genetic Risk Factors for Alzheimer\u2019s Disease on Brain Glucose Metabolism. DOI: 10.1007\/s12035-021-02297-x\/Published.","DOI":"10.1007\/s12035-021-02297-x"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0205","doi-asserted-by":"crossref","unstructured":"Cho, Y., Bae, H. G., Okun, E., Arumugam, T. V., & Jo, D. G. (2022). Physiology and pharmacology of amyloid precursor protein. Pharmacol. Therapeut. (Vol. 235). Elsevier Inc. DOI: 10.1016\/j.pharmthera.2022.108122.","DOI":"10.1016\/j.pharmthera.2022.108122"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0210","article-title":"Recent advances in the molecular signaling pathways of Substance P in Alzheimer\u2019s disease: Link to neuroinflammation associated with toll-like receptors","volume":"733","author":"Gurram","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"24","key":"10.1016\/j.neuroscience.2025.10.050_b0215","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-\u03b242 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"PNAS"},{"issue":"44","key":"10.1016\/j.neuroscience.2025.10.050_b0220","doi-asserted-by":"crossref","first-page":"9446","DOI":"10.1021\/bi2010569","article-title":"Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms","volume":"50","author":"Combs","year":"2011","journal-title":"Biochemistry"},{"issue":"9\u201310","key":"10.1016\/j.neuroscience.2025.10.050_b0235","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.micinf.2018.01.003","article-title":"Serine protease inhibitors containing a Kunitz domain: their role in modulation of host inflammatory responses and parasite survival","volume":"20","author":"de Magalh\u00e3es","year":"2018","journal-title":"Microbes Infect."},{"issue":"22","key":"10.1016\/j.neuroscience.2025.10.050_b0240","first-page":"12087","article-title":"Kinetic diversity of amyloid oligomers","volume":"117","author":"Dear","year":"2020","journal-title":"Biophys. Comput. Biol."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0250","doi-asserted-by":"crossref","unstructured":"Chaudhary, A., Javvaji, K., Pradhan, S. R., Vallamkondu, J., Dey, A., Kalra, R. S., Jha, N. K., Jha, S. K., Reddy, P. H., & Kandimalla, R. (2022). Altered glucose metabolism in Alzheimer\u2019s disease: Role of mitochondrial dysfunction and oxidative stress. Free Rad. Biol. Med. (Vol. 193, pp. 134\u2013157). Elsevier Inc. DOI: 10.1016\/j.freeradbiomed.2022.09.032.","DOI":"10.1016\/j.freeradbiomed.2022.09.032"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0255","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI28769","article-title":"Oxidative stress mediates tau-induced neurodegeneration in Drosophila","volume":"117","author":"Dias-Santagata","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0260","doi-asserted-by":"crossref","unstructured":"Duan, P., Dregni, A. J., Mammeri, N. El, & Hong, M. (2023). Structure of the nonhelical filament of the Alzheimer\u2019s disease tau core. Proceed. Natl. Acad. Sci. USA, 120(44). DOI: 10.1073\/pnas.2310067120.","DOI":"10.1073\/pnas.2310067120"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.10.050_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107730","article-title":"Alzheimer\u2019s disease seeded tau forms paired helical filaments yet lacks seeding potential","volume":"300","author":"Duan","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0270","doi-asserted-by":"crossref","unstructured":"El Mammeri, N., Dregni, A. J., Duan, P., & Hong, M. (2024). Structures of AT8 and PHF1 phosphomimetic tau: Insights into the posttranslational modification code of tau aggregation. Proceed. Natl. Acad. Sci. USA, 121(10). DOI: 10.1073\/pnas.2316175121.","DOI":"10.1073\/pnas.2316175121"},{"issue":"8","key":"10.1016\/j.neuroscience.2025.10.050_b0275","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1134\/S0006297922080028","article-title":"Effect of Tau Protein on Mitochondrial Functions","volume":"87","author":"Epremyan","year":"2022","journal-title":"Biochemistry (Moscow)"},{"issue":"21","key":"10.1016\/j.neuroscience.2025.10.050_b0280","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1021\/bi992933h","article-title":"Alzheimer\u2019s disease amyloid propagation by a template-dependent dock- lock mechanism","volume":"39","author":"Esler","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0285","doi-asserted-by":"crossref","unstructured":"Fanlo-Ucar, H., Pic\u00f3n-Pag\u00e8s, P., Herrera-Fern\u00e1ndez, V., ILL-Raga, G., & Mu\u00f1oz, F. J. (2024). The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer\u2019s Disease Etiopathology. Antioxidants (Vol. 13, Issue 10). Multidisciplinary Digital Publishing Institute (MDPI). DOI: 10.3390\/antiox13101208.","DOI":"10.3390\/antiox13101208"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0290","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Calle, R., Konings, S. C., Fronti\u00f1\u00e1n-Rubio, J., Garc\u00eda-Revilla, J., Camprub\u00ed-Ferrer, L., Svensson, M., Martinson, I., Boza-Serrano, A., Venero, J. L., Nielsen, H. M., Gouras, G. K., & Deierborg, T. (2022). APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases. Mol. Neurodegener. (Vol. 17, Issue 1). BioMed Central Ltd. DOI: 10.1186\/s13024-022-00566-4.","DOI":"10.1186\/s13024-022-00566-4"},{"issue":"52","key":"10.1016\/j.neuroscience.2025.10.050_b0295","doi-asserted-by":"crossref","first-page":"43223","DOI":"10.1074\/jbc.M112.396176","article-title":"Tau oligomers impair artificial membrane integrity and cellular viability","volume":"287","author":"Flach","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0305","doi-asserted-by":"crossref","unstructured":"Foster, E. M., Dangla-Valls, A., Lovestone, S., Ribe, E. M., & Buckley, N. J. (2019). Clusterin in Alzheimer\u2019s disease: Mechanisms, genetics, and lessons from other pathologies. Front. Neurosci. (Vol. 13, Issue FEB). Frontiers Media S.A. DOI: 10.3389\/fnins.2019.00164.","DOI":"10.3389\/fnins.2019.00164"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0310","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-52681-z","article-title":"A structural rationale for reversible vs irreversible amyloid fibril formation from a single protein","volume":"15","author":"Frey","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0320","doi-asserted-by":"crossref","unstructured":"Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023). Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Sign. Transduct. Target. Therapy (Vol. 8, Issue 1). Springer Nature. DOI: 10.1038\/s41392-023-01588-0.","DOI":"10.1038\/s41392-023-01588-0"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0325","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-025-02864-9","article-title":"High resolution autoradiography of [18F]MK-6240 and [18F]Flortaucipir shows similar neurofibrillary tangle binding patterns preferentially recognizing middling neurofibrillary tangle maturity","volume":"149","author":"Ghatamaneni","year":"2025","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.10.050_b0330","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1021\/acs.jmedchem.4c00045","article-title":"Dual inhibitors of brain carbonic anhydrases and monoamine oxidase-B efficiently protect against amyloid-\u03b2-induced neuronal toxicity, oxidative stress, and mitochondrial dysfunction","volume":"67","author":"Giovannuzzi","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0350","doi-asserted-by":"crossref","unstructured":"Goto, Y., Nakajima, K., Yamamoto, S., & Yamaguchi, K. (2024). Supersaturation, a Critical Factor Underlying Proteostasis of Amyloid Fibril Formation. J. Molecul. Biol. (Vol. 436, Issue 14). Academic Press. Doi: 10.1016\/j.jmb.2024.168475.","DOI":"10.1016\/j.jmb.2024.168475"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0355","article-title":"The broad impact of TOM40 on Neurodegenerative Diseases in Aging","volume":"1","author":"Gottschalk","year":"2015","journal-title":"J. Parkinson\u2019s Dis. Alzheim. Dis."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.050_b0360","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neurobiolaging.2010.03.025","article-title":"The genetic architecture of Alzheimer\u2019s disease: Beyond APP, PSENS and APOE","volume":"33","author":"Guerreiro","year":"2012","journal-title":"Neurobiol. Agi."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0370","doi-asserted-by":"crossref","unstructured":"Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., Villemagne, V. L., Aisen, P., Vendruscolo, M., Iwatsubo, T., Masters, C. L., Cho, M., Lannfelt, L., Cummings, J. L., & Vergallo, A. (2021). The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease. Molecul. Psych. (Vol. 26, Issue 10, pp. 5481\u20135503). Springer Nature. DOI: 10.1038\/s41380-021-01249-0.","DOI":"10.1038\/s41380-021-01249-0"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.10.050_b0375","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/anie.202010098","article-title":"Protofibril\u2013Fibril Interactions Inhibit Amyloid Fibril Assembly by Obstructing Secondary Nucleation","volume":"60","author":"Hasecke","year":"2021","journal-title":"Angewand. Chem. \u2013 Int. Ed."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0380","doi-asserted-by":"crossref","unstructured":"Heneka, M. T., Carson, M. J., Khoury, J. El, Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., Herrup, K., Frautschy, S. A., Finsen, B., Brown, G. C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., \u2026 Kummer, M. P. (2015). Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. (Vol. 14, Issue 4, pp. 388\u2013405). Lancet Publishing Group. Doi: 10.1016\/S1474-4422(15)70016-5.","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0385","doi-asserted-by":"crossref","unstructured":"Heneka, M. T., van der Flier, W. M., Jessen, F., Hoozemanns, J., Thal, D. R., Boche, D., Brosseron, F., Teunissen, C., Zetterberg, H., Jacobs, A. H., Edison, P., Ramirez, A., Cruchaga, C., Lambert, J. C., Laza, A. R., Sanchez-Mut, J. V., Fischer, A., Castro-Gomez, S., Stein, T. D., \u2026 Riechers, S. P. (2025). Neuroinflammation in Alzheimer disease. Nat. Rev. Immunol. (Vol. 25, Issue 5, pp. 321\u2013352). Nature Research. DOI: 10.1038\/s41577-024-01104-7.","DOI":"10.1038\/s41577-024-01104-7"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0390","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez, F., Ferrer, I., P\u00e9rez, M., Zabala, J. C., del Rio, J. A., & Avila, J. (2023). Tau Aggregation. Neurosci. (Vol. 518, pp. 64\u201369). Elsevier Ltd. DOI: 10.1016\/j.neuroscience.2022.04.024.","DOI":"10.1016\/j.neuroscience.2022.04.024"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0395","doi-asserted-by":"crossref","unstructured":"Hook, V., Yoon, M., Mosier, C., Ito, G., Podvin, S., Head, B. P., Rissman, R., O\u2019Donoghue, A. J., & Hook, G. (2020). Cathepsin B in neurodegeneration of Alzheimer\u2019s disease, traumatic brain injury, and related brain disorders. Biochim. Biophys. Acta \u2013 Protein. Proteom. (Vol. 1868, Issue 8). Elsevier B.V. DOI: 10.1016\/j.bbapap.2020.140428.","DOI":"10.1016\/j.bbapap.2020.140428"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0405","doi-asserted-by":"crossref","unstructured":"Hur, J. Y. (2022). \u03b3-Secretase in Alzheimer\u2019s disease. Exp. Molecul. Med. (Vol. 54, Issue 4, pp. 433\u2013446). Springer Nature. Doi: 10.1038\/s12276-022-00754-8.","DOI":"10.1038\/s12276-022-00754-8"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0415","doi-asserted-by":"crossref","unstructured":"Iqbal, K. (2024). Tau and Alzheimer\u2019s disease: Past, present and future. In Cytoskeleton (Vol. 81, Issue 1, pp. 116\u2013121). John Wiley and Sons Inc. DOI: 10.1002\/cm.21822.","DOI":"10.1002\/cm.21822"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117708","article-title":"Protective effect of a hydromethanolic extract from Fraxinus excelsior L. bark against a rat model of aluminum chloride-induced Alzheimer\u2019s disease: relevance to its anti-inflammatory and antioxidant effects","volume":"323","author":"Iranpanah","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0425","doi-asserted-by":"crossref","unstructured":"Isei, M. O., Crockett, M., Chen, E., Rodwell-Bullock, J., Carroll, T., Girardi, P. A., Nehrke, K., & Johnson, G. V. W. (2025). Tau phosphorylation suppresses oxidative stress-induced mitophagy via FKBP8 receptor modulation. PLoS ONE, 20(1 January). DOI: 10.1371\/journal.pone.0307358.","DOI":"10.1371\/journal.pone.0307358"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0430","doi-asserted-by":"crossref","unstructured":"Jackson, R. J., Hyman, B. T., & Serrano-Pozo, A. (2024). Multifaceted roles of APOE in Alzheimer disease. Nat. Rev. Neurol. (Vol. 20, Issue 8, pp. 457\u2013474). Nature Research. DOI: 10.1038\/s41582-024-00988-2.","DOI":"10.1038\/s41582-024-00988-2"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0435","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2024.01.005","article-title":"Brain structural indicators of \u03b2-amyloid neuropathology","volume":"136","author":"Jang","year":"2024","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0445","doi-asserted-by":"crossref","unstructured":"Kaltschmidt, B., Czaniera, N. J., Schulten, W., & Kaltschmidt, C. (2024). NF-\u03baB in Alzheimer\u2019s Disease: Friend or Foe? Opposite Functions in Neurons and Glial Cells. Int. J. Molecul. Sci. (Vol. 25, Issue 21). Multidisciplinary Digital Publishing Institute (MDPI). DOI: 10.3390\/ijms252111353.","DOI":"10.3390\/ijms252111353"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0450","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-023-00718-2","article-title":"Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt\/\u03b2-catenin\/NeuroD1 pathway","volume":"29","author":"Kang","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0455","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neurobiolaging.2019.09.004","article-title":"The role of TREM2 in Alzheimer\u2019s disease; evidence from transgenic mouse models","volume":"86","author":"Karanfilian","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0465","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0470","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/731526","article-title":"Structure and pathology of tau protein in Alzheimer disease","author":"Kolarova","year":"2012","journal-title":"Int. J. Alzheim. Dis."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.10.050_b0475","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10354-021-00819-9","article-title":"Genetics of Alzheimer\u2019s disease","volume":"171","author":"K\u00f6nig","year":"2021","journal-title":"Wien. Med. Wochenschr."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.10.050_b0480","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","article-title":"Is Alzheimer disease a disease?","volume":"20","author":"Korczyn","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.10.050_b0485","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/jamaneurol.2015.0979","article-title":"R47H variant of TREM2 associated with Alzheimer disease in a large late-onset family clinical, genetic, and neuropathological study","volume":"72","author":"Korvatska","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0490","doi-asserted-by":"crossref","unstructured":"Kowalczyk, P., Sulejczak, D., Kleczkowska, P., Bukowska-O\u015bko, I., Kucia, M., Popiel, M., Wietrak, E., Kramkowski, K., Wrzosek, K., & Kaczy\u0144ska, K. (2021). Mitochondrial oxidative stress\u2014a causative factor and therapeutic target in many diseases. Int. J. Molecul. Sci. (Vol. 22, Issue 24). MDPI. DOI: 10.3390\/ijms222413384.","DOI":"10.3390\/ijms222413384"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0495","doi-asserted-by":"crossref","unstructured":"Kurz, C., Walker, L., Rauchmann, B. S., & Perneczky, R. (2022). Dysfunction of the blood\u2013brain barrier in Alzheimer\u2019s disease: evidence from human studies. Neuropathol. Appl. Neurobiol. (Vol. 48, Issue 3). John Wiley and Sons Inc. Doi: 10.1111\/nan.12782.","DOI":"10.1111\/nan.12782"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.050_b0500","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuron.2019.07.010","article-title":"A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP \u03b2-CTFs","volume":"104","author":"Kwart","year":"2019","journal-title":"Not A\u03b2. Neuron"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0505","article-title":"The Cortical Neuritic Dystrophy of Alzheimer\u2019s Disease: Nature, Significance, and Possible Pathogenesis","volume":"6","author":"Lamer","year":"1995","journal-title":"Dementia"},{"issue":"8","key":"10.1016\/j.neuroscience.2025.10.050_b0510","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13080951","article-title":"Ecklonia cava Ameliorates Cognitive Impairment on Amyloid \u03b2-Induced Neurotoxicity by Modulating Oxidative Stress and Synaptic Function in Institute of Cancer Research (ICR) Mice","volume":"13","author":"Lee","year":"2024","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.10.050_b0515","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/glia.24677","article-title":"Contributions of Genetic Variation in Astrocytes to Cell and Molecular Mechanisms of Risk and Resilience to Late-Onset Alzheimer\u2019s Disease","volume":"73","author":"Lee","year":"2025","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0520","doi-asserted-by":"crossref","unstructured":"Lee, J. H., Wolfe, D. M., Darji, S., McBrayer, M. K., Colacurcio, D. J., Kumar, A., Stavrides, P., Mohan, P. S., & Nixon, R. A. (2020). \u03b22-adrenergic Agonists Rescue Lysosome Acidification and Function in PSEN1 Deficiency by Reversing Defective ER-to-lysosome Delivery of ClC-7. J. Mol. Biol. (Vol. 432, Issue 8, pp. 2633\u20132650). Academic Press. DOI: 10.1016\/j.jmb.2020.02.021.","DOI":"10.1016\/j.jmb.2020.02.021"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.050_b0525","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0530","doi-asserted-by":"crossref","unstructured":"Li Puma, D. D., Piacentini, R., & Grassi, C. (2021). Does Impairment of Adult Neurogenesis Contribute to Pathophysiology of Alzheimer\u2019s Disease? A Still Open Question. Front. Molecul. Neurosci. (Vol. 13). Frontiers Media S.A. DOI: 10.3389\/fnmol.2020.578211.","DOI":"10.3389\/fnmol.2020.578211"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0535","article-title":"Human wild-type full-length tau accumulation disrupts mitochondrial dynamics and the functions via increasing mitofusins","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0540","doi-asserted-by":"crossref","unstructured":"Li, Y., Xia, X., Wang, Y., & Zheng, J. C. (2022). Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer\u2019s disease. J. Neuroinflammat. (Vol. 19, Issue 1). BioMed Central Ltd. DOI: 10.1186\/s12974-022-02613-9.","DOI":"10.1186\/s12974-022-02613-9"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0545","doi-asserted-by":"crossref","unstructured":"Li, Z., Shue, F., Zhao, N., Shinohara, M., & Bu, G. (2020). APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease. Mol. Neurodegenerat. (Vol. 15, Issue 1). BioMed Central Ltd. DOI: 10.1186\/s13024-020-00413-4.","DOI":"10.1186\/s13024-020-00413-4"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0550","doi-asserted-by":"crossref","DOI":"10.1039\/D3LC00507K","article-title":"Comparison between dynamic versus static models and real-time monitoring of neuronal dysfunction in an amyloid-\u00df induced neuronal toxic model on a chip platform","author":"Liang","year":"2024","journal-title":"Lab Chip"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.050_b0555","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein e and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.10.050_b0565","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1007\/s12035-020-02034-w","article-title":"Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell Death","volume":"57","author":"Liu","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0575","doi-asserted-by":"crossref","unstructured":"L\u00f6vestam, S., Wagstaff, J. L., Katsinelos, T., Shi, J., Freund, S. M. V., Goedert, M., & Scheres, S. H. W. (2024). Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filaments. Doi: 10.1101\/2024.10.23.619846.","DOI":"10.1101\/2024.10.23.619846"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0580","doi-asserted-by":"crossref","unstructured":"Lu, M., Collins, E. C., Devous, M. D., Burnham, S. C., Iaccarino, L., Pontecorvo, M. J., & Fleisher, A. S. (2024). A review of the flortaucipir literature for positron emission tomography imaging of tau neurofibrillary tangles. Brain Commun. (Vol. 6, Issue 1). Oxford University Press. DOI: 10.1093\/braincomms\/fcad305.","DOI":"10.1093\/braincomms\/fcad305"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0585","article-title":"Alzheimer\u2019s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph","volume":"11","author":"Magno","year":"2019","journal-title":"Alzheim. Res. Therap."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0590","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-022-00516-0","article-title":"Selective reduction of astrocyte apoE3 and apoE4 strongly reduces A\u03b2 accumulation and plaque-related pathology in a mouse model of amyloidosis","volume":"17","author":"Mahan","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.10.050_b0595","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1021\/acsmedchemlett.4c00283","article-title":"Fluorescent peptides sequester redox copper to mitigate oxidative stress, amyloid toxicity, and neuroinflammation","volume":"15","author":"Mandal","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0600","doi-asserted-by":"crossref","unstructured":"Mattsson-Carlgren, N. (2024). Disentangling genetic risks for development and progression of Alzheimer\u2019s disease. In Brain (Vol. 147, Issue 8, pp. 2604\u20132606). Oxford University Press. DOI: 10.1093\/brain\/awae237.","DOI":"10.1093\/brain\/awae237"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.10.050_b0605","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The role of Tau in Alzheimer\u2019s disease and related disorders","volume":"17","author":"Medeiros","year":"2011","journal-title":"CNS Neurosci. Therapeut."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0610","doi-asserted-by":"crossref","unstructured":"Meng, X., Song, Q., Liu, Z., Liu, X., Wang, Y., & Liu, J. (2024). Neurotoxic \u03b2-amyloid oligomers cause mitochondrial dysfunction\u2014the trigger for PANoptosis in neurons. Front. Aging Neurosci. (Vol. 16). Frontiers Media SA. DOI: 10.3389\/fnagi.2024.1400544.","DOI":"10.3389\/fnagi.2024.1400544"},{"issue":"21","key":"10.1016\/j.neuroscience.2025.10.050_b0615","article-title":"Microglia and Alzheimer\u2019s Disease","volume":"23","author":"Merighi","year":"2022","journal-title":"Int. J. Molecul. Sci."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0620","doi-asserted-by":"crossref","unstructured":"Mietelska-Porowska, A., Wasik, U., Goras, M., Filipek, A., & Niewiadomska, G. (2014). Tau protein modifications and interactions: Their role in function and dysfunction. Int. J. Molecul. Sci\/ (Vol. 15, Issue 3, pp. 4671\u20134713). MDPI AG. DOI: 10.3390\/ijms15034671.","DOI":"10.3390\/ijms15034671"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0630","doi-asserted-by":"crossref","unstructured":"Muralidar, S., Ambi, S. V., Sekaran, S., Thirumalai, D., & Palaniappan, B. (2020). Role of tau protein in Alzheimer\u2019s disease: The prime pathological player. Int. J. Biol. Macromol. (Vol. 163, pp. 1599\u20131617). Elsevier B.V. DOI: 10.1016\/j.ijbiomac.2020.07.327.","DOI":"10.1016\/j.ijbiomac.2020.07.327"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0635","doi-asserted-by":"crossref","unstructured":"Narasimhan, S., Holtzman, D. M., Apostolova, L. G., Cruchaga, C., Masters, C. L., Hardy, J., Villemagne, V. L., Bell, J., Cho, M., & Hampel, H. (2024). Apolipoprotein E in Alzheimer\u2019s disease trajectories and the next-generation clinical care pathway. In Nat. Neurosci. (Vol. 27, Issue 7, pp. 1236\u20131252). Nature Research. DOI: 10.1038\/s41593-024-01669-5.","DOI":"10.1038\/s41593-024-01669-5"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0640","doi-asserted-by":"crossref","unstructured":"Nguyen, P. H., Suan Li, M., Stock, G., Straub, J. E., & Thirumalai, D. (2006). Monomer adds to preformed structured oligomers of A-peptides by a two-stage dock-lock mechanism. https:\/\/www.pnas.org.","DOI":"10.1073\/pnas.0607440104"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0645","doi-asserted-by":"crossref","unstructured":"Niewiadomska, G., Niewiadomski, W., Steczkowska, M., & Gasiorowska, A. (2021). Tau oligomers neurotoxicity. Life (Vol. 11, Issue 1, pp. 1\u201328). MDPI AG. DOI: 10.3390\/life11010028.","DOI":"10.3390\/life11010028"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0650","doi-asserted-by":"crossref","unstructured":"Niu, Z., Gui, X., Feng, S., & Reif, B. (2024). Aggregation Mechanisms and Molecular Structures of Amyloid-\u03b2 in Alzheimer\u2019s Disease. Chem. Europ. J. (Vol. 30, Issue 48). John Wiley and Sons Inc. DOI: 10.1002\/chem.202400277.","DOI":"10.1002\/chem.202400277"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.10.050_b0655","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1096\/fj.201700359","article-title":"Amyloid precursor protein & endosomal-lysosomal dysfunction in Alzheimer\u2019s disease: Inseparable partners in a multifactorial disease","volume":"31","author":"Nixon","year":"2017","journal-title":"FASEB J."},{"issue":"40","key":"10.1016\/j.neuroscience.2025.10.050_b0660","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: Potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"issue":"43","key":"10.1016\/j.neuroscience.2025.10.050_b0665","doi-asserted-by":"crossref","first-page":"14421","DOI":"10.1021\/jp9050098","article-title":"Thermodynamic perspective on the dock-lock growth mechanism of amyloid fibrils","volume":"113","author":"O\u2019Brien","year":"2009","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0670","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer\u2019s disease","volume":"34","author":"O\u2019Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.050_b0675","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1074\/jbc.M113.498246","article-title":"Characterization of intermediate steps in amyloid beta (A\u03b2) production under near-native conditions","volume":"289","author":"Olsson","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0680","doi-asserted-by":"crossref","unstructured":"K. Ono Ono, K. (2018). Alzheimer\u2019s disease as oligomeropathy. Neurochem. Int. (Vol. 119, pp. 57\u201370). Elsevier Ltd. DOI: 10.1016\/j.neuint.2017.08.010.","DOI":"10.1016\/j.neuint.2017.08.010"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0685","doi-asserted-by":"crossref","first-page":"105208","DOI":"10.1016\/j.neuint.2021.105208","article-title":"Aggregation and structure of amyloid \u03b2-protein","volume":"151","author":"Ono","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0690","doi-asserted-by":"crossref","unstructured":"P\u00e1lmad\u00f3ttir, T., Getachew, J., Ortigosa-Pascual, L., Axell, E., Wei, J., Olsson, U., Knowles, T. P. J., & Linse, S. (2025). On the reversibility of amyloid fibril formation. Biophys. Rev. (Vol. 6, Issue 1). American Institute of Physics. DOI: 10.1063\/5.0236947.","DOI":"10.1063\/5.0236947"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0695","doi-asserted-by":"crossref","unstructured":"Palmer, J. M., Huentelman, M., & Ryan, L. (2023). More than just risk for Alzheimer\u2019s disease: APOE \u03b54\u2019s impact on the aging brain. Trend. Neurosci. (Vol. 46, Issue 9, pp. 750\u2013763). Elsevier Ltd. DOI: 10.1016\/j.tins.2023.06.003.","DOI":"10.1016\/j.tins.2023.06.003"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0700","unstructured":"Pantelopulos, G. A., Abraham, C. B., & Straub, J. E. (2025). Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-\u03b2 Protein and Alzheimer\u2019s Disease. 17. DOI: 10.1146\/annurev-biophys-062823."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0705","doi-asserted-by":"crossref","unstructured":"Parra Bravo, C., Naguib, S. A. Gan, L. (2024). Cellular and pathological functions of tau. Nat. Rev. Molecul. Cell Biol. (Vol. 25, Issue 11, pp. 845\u2013864). Nature Research. DOI: 10.1038\/s41580-024-00753-9.","DOI":"10.1038\/s41580-024-00753-9"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0710","doi-asserted-by":"crossref","unstructured":"Pasqualetti, G., Thayanandan, T., & Edison, P. (2022). Influence of genetic and cardiometabolic risk factors in Alzheimer\u2019s disease. Age. Res. Rev. (Vol. 81). Elsevier Ireland Ltd. DOI: 10.1016\/j.arr.2022.101723.","DOI":"10.1016\/j.arr.2022.101723"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0715","doi-asserted-by":"crossref","unstructured":"Patow, G. A., Escrichs, A., Martinez-Molina, N., Ritter, P., & Deco, G. (2024). Altered intrinsic ignition dynamics linked to Amyloid-\u03b2 and tau pathology in Alzheimer\u2019s disease. DOI: 10.1101\/2024.03.29.587333.","DOI":"10.1101\/2024.03.29.587333"},{"issue":"8","key":"10.1016\/j.neuroscience.2025.10.050_b0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108420","article-title":"Endosomal dysfunction induced by directly overactivating Rab5 recapitulates prodromal and neurodegenerative features of Alzheimer\u2019s disease","volume":"33","author":"Pensalfini","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0725","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12035-015-9640-1","article-title":"Phosphatase 2A inhibition affects endoplasmic reticulum and mitochondria homeostasis via cytoskeletal alterations in brain endothelial cells","volume":"54","author":"Pl\u00e1cido","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.050_b0730","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archneurol.2008.588","article-title":"PGC-1\u03b1 expression decreases in the Alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0735","doi-asserted-by":"crossref","unstructured":"Rajani, R. M., Ellingford, R., Hellmuth, M., Harris, S. S., Taso, O. S., Graykowski, D., Lam, F. K. W., Arber, C., Fertan, E., Danial, J. S. H., Swire, M., Lloyd, M., Giovannucci, T. A., Bourdenx, M., Klenerman, D., Vassar, R., Wray, S., Frigerio, C. S., & Busche, M. A. (2024). Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer\u2019s disease. PLoS Biol., 22(7 July). DOI: 10.1371\/journal.pbio.3002727.","DOI":"10.1371\/journal.pbio.3002727"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0740","doi-asserted-by":"crossref","unstructured":"Raulin, A. C., Doss, S. V., Trottier, Z. A., Ikezu, T. C., Bu, G., & Liu, C. C. (2022). ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. In Molecular Neurodegeneration (Vol. 17, Issue 1). BioMed Central Ltd. DOI: 10.1186\/s13024-022-00574-4.","DOI":"10.1186\/s13024-022-00574-4"},{"issue":"23","key":"10.1016\/j.neuroscience.2025.10.050_b0745","doi-asserted-by":"crossref","first-page":"8946","DOI":"10.1039\/D4SC00560K","article-title":"Non-fibril amyloid aggregation at the air\/water interface: self-adaptive pathway resulting in a 2D Janus nanofilm","volume":"15","author":"Ren","year":"2024","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0750","doi-asserted-by":"crossref","DOI":"10.1186\/s12868-021-00643-2","article-title":"MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer\u2019s disease","volume":"22","author":"Ringland","year":"2021","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0755","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200420640","article-title":"Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology","volume":"114","author":"Rissman","year":"2004","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0765","article-title":"A review: Inflammatory process in Alzheimer\u2019s disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"Scient World J."},{"issue":"16\u201318","key":"10.1016\/j.neuroscience.2025.10.050_b0770","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1089\/ars.2021.0177","article-title":"Altered metabolism in Alzheimer disease brain: role of oxidative stress","volume":"36","author":"Rummel","year":"2022","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.050_b0775","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jmb.2006.07.011","article-title":"Quaternary structure of a mature amyloid fibril from Alzheimer\u2019s A\u03b2(1-40) peptide","volume":"362","author":"Sachse","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0780","doi-asserted-by":"crossref","unstructured":"Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Ch\u00e9telat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021). Alzheimer\u2019s disease. Lancet (Vol. 397, Issue 10284, pp. 1577\u20131590). Elsevier B.V. DOI: 10.1016\/S0140-6736(20)32205-4.","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0785","doi-asserted-by":"crossref","unstructured":"Schmidt, V., Subkhangulova, A., & Willnow, T. E. (2017). Sorting receptor SORLA: cellular mechanisms and implications for disease. Cellul. Molecul. Life Sci. (Vol. 74, Issue 8, pp. 1475\u20131483). Birkhauser Verlag AG. DOI: 10.1007\/s00018-016-2410-z.","DOI":"10.1007\/s00018-016-2410-z"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.050_b0790","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JAD-132543","article-title":"Amyloid-\u03b2 peptides are generated in mitochondria-associated endoplasmic reticulum membranes","volume":"43","author":"Schreiner","year":"2015","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0800","doi-asserted-by":"crossref","unstructured":"Serrano-Pozo, A., Das, S., & Hyman, B. T. (2021). APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. (Vol. 20, Issue 1, pp. 68\u201380). Lancet Publishing Group. DOI: 10.1016\/S1474-4422(20)30412-9.","DOI":"10.1016\/S1474-4422(20)30412-9"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0805","doi-asserted-by":"crossref","unstructured":"Sethi, P., C, R. D., Borra, R., Vahora, S., Vashi, A., Mukherjee, R. K., Pavani, B., & Tiwari, G. (2024). Mechanistic Insights into Tau Protein-Mediated Regulation of Oxidative Stress. In Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chin. J. Appl. Physiol. (Vol. 40, p. e20240028). DOI: 10.62958\/j.cjap.2024.028.","DOI":"10.62958\/j.cjap.2024.028"},{"issue":"7880","key":"10.1016\/j.neuroscience.2025.10.050_b0815","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","article-title":"Structure-based classification of tauopathies","volume":"598","author":"Shi","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0820","doi-asserted-by":"crossref","unstructured":"Shoshan-Barmatz, V., Nahon-Crystal, E., Shteinfer-Kuzmine, A., & Gupta, R. (2018). VDAC1, mitochondrial dysfunction, and Alzheimer\u2019s disease. Pharmacol. Res. (Vol. 131, pp. 87\u2013101). Academic Press. DOI: 10.1016\/j.phrs.2018.03.010.","DOI":"10.1016\/j.phrs.2018.03.010"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136078","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: Therapeutic implications of lithium","volume":"760","author":"Singulani","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.10.050_b0830","doi-asserted-by":"crossref","DOI":"10.3390\/ph17081039","article-title":"Anthocyanin-Rich Fraction of Black Rice Bran Extract Protects against Amyloid \u03b2-Induced Oxidative Stress, Endoplasmic Reticulum Stress, and Neuronal Apoptosis in SK-N-SH Cells","volume":"17","author":"Sivasinprasasn","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.10.050_b0835","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.21873\/invivo.13181","article-title":"Abnormal Hyperphosphorylation of Tau in Canine Immune-mediated Meningoencephalitis","volume":"37","author":"Son","year":"2023","journal-title":"In Vivo"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0840","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-015-0054-3","article-title":"Statins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway","volume":"10","author":"Son","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0845","doi-asserted-by":"crossref","unstructured":"Srivastava, A. K., Pittman, J. M., Zerweck, J., Venkata, B. S., Moore, P. C., Sachleben, J. R., & Meredith, S. C. (2019). \u03b2-Amyloid aggregation and heterogeneous nucleation. In Prot. Sci. (Vol. 28, Issue 9, pp. 1567\u20131581). Blackwell Publishing Ltd. Doi: 10.1002\/pro.3674.","DOI":"10.1002\/pro.3674"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0850","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl8809","article-title":"Alzheimer\u2019s disease: Ablating single master site abolishes tau hyperphosphorylation","volume":"8","author":"Stefanoska","year":"2022","journal-title":"In Sci. Adv"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.10.050_b0855","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biopsych.2012.05.026","article-title":"Alzheimer risk variant CLU and brain function during aging","volume":"73","author":"Thambisetty","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0865","doi-asserted-by":"crossref","unstructured":"Therriault, J., Schindler, S. E., Salvad\u00f3, G., Pascoal, T. A., Benedet, A. L., Ashton, N. J., Karikari, T. K., Apostolova, L., Murray, M. E., Verberk, I., Vogel, J. W., La Joie, R., Gauthier, S., Teunissen, C., Rabinovici, G. D., Zetterberg, H., Bateman, R. J., Scheltens, P., Blennow, K., \u2026 Rosa-Neto, P. (2024). Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat. Rev. Neurol. (Vol. 20, Issue 4, pp. 232\u2013244). Nature Research. Doi: 10.1038\/s41582-024-00942-2.","DOI":"10.1038\/s41582-024-00942-2"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0875","doi-asserted-by":"crossref","unstructured":"Toral-Rios, D., Pichardo-Rojas, P. S., Alonso-Vanegas, M., & Campos-Pe\u00f1a, V. (2020). GSK3\u03b2 and Tau Protein in Alzheimer\u2019s Disease and Epilepsy. Front. Cellular Neurosci. (Vol. 14). Frontiers Media S.A. DOI: 10.3389\/fncel.2020.00019.","DOI":"10.3389\/fncel.2020.00019"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0880","doi-asserted-by":"crossref","unstructured":"Torres, A., Rivera, B., Polanco, C., Jara, C., & Tapia-Rojas, C. (2022). Phosphorylated tau as a toxic agent in synaptic mitochondria: Implications in aging and Alzheimer\u2019s disease. Neur. Regenerat. Res. (Vol. 17, Issue 8, pp. 1645\u20131651). Wolters Kluwer Medknow Publications. DOI: 10.4103\/1673-5374.332125.","DOI":"10.4103\/1673-5374.332125"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.10.050_b0885","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1517\/14656566.6.5.683","article-title":"Microtubule-stabilising drugs for therapy of Alzheimer\u2019s disease and other neurodegenerative disorders with axonal transport impairments","volume":"6","author":"Trojanowski","year":"2005","journal-title":"Exp. Opin. Pharmacother."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0890","doi-asserted-by":"crossref","unstructured":"Turner, P. R., O\u2019Connor, K., Tate, W. P., & Abraham, W. C. (2003). Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Progr. Neurobiol. (Vol. 70, Issue 1, pp. 1\u201332). Elsevier Ltd. DOI: 10.1016\/S0301-0082(03)00089-3.","DOI":"10.1016\/S0301-0082(03)00089-3"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0895","doi-asserted-by":"crossref","unstructured":"Uddin, J., Fariha, T., Shumi, S. S., & Khandoker, F. (2024). Factors Contributing to Alzheimer\u2019s Disease in Older Adult Populations: A Narrative Review. Doi: 10.20944\/preprints202406.1892.v1.","DOI":"10.20944\/preprints202406.1892.v1"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0900","doi-asserted-by":"crossref","unstructured":"Van Acker, Z. P., Bretou, M., & Annaert, W. (2019). Endo-lysosomal dysregulations and late-onset Alzheimer\u2019s disease: Impact of genetic risk factors. Mol. Neurodegenerat. (Vol. 14, Issue 1). BioMed Central Ltd. Doi: 10.1186\/s13024-019-0323-7.","DOI":"10.1186\/s13024-019-0323-7"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0905","doi-asserted-by":"crossref","unstructured":"Ventura-Clapier, R., Garnier, A., & Veksler, V. (2008). Transcriptional control of mitochondrial biogenesis: The central role of PGC-1\u03b1. Cardiovascul. Res. (Vol. 79, Issue 2, pp. 208\u2013217). Oxford University Press. Doi: 10.1093\/cvr\/cvn098.","DOI":"10.1093\/cvr\/cvn098"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0910","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","article-title":"Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0915","doi-asserted-by":"crossref","unstructured":"Wang, J. Z., Xia, Y. Y., Grundke-Iqbal, I., & Iqbal, K. (2013). Abnormal hyperphosphorylation of tau: Sites, regulation, and molecular mechanism of neurofibrillary degeneration. J. Alzheim. Dis. (Vol. 33, Issue SUPPL. 1). IOS Press. DOI: 10.3233\/JAD-2012-129031.","DOI":"10.3233\/JAD-2012-129031"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0920","doi-asserted-by":"crossref","unstructured":"Wang, W., Zhao, F., Ma, X., Perry, G., & Zhu, X. (2020). Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: Recent advances. Molecul. Neurodegenerat. (Vol. 15, Issue 1). BioMed Central Ltd. Doi: 10.1186\/s13024-020-00376-6.","DOI":"10.1186\/s13024-020-00376-6"},{"issue":"21","key":"10.1016\/j.neuroscience.2025.10.050_b0925","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1073\/pnas.1524807113","article-title":"High-speed atomic force microscopy reveals structural dynamics of amyloid \u03b21-42 aggregates","volume":"113","author":"Watanabe-Nakayama","year":"2016","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0930","doi-asserted-by":"crossref","unstructured":"Wei, H., Zhang, H. liang, Wang, X. chuan, Xie, J. zhao, An, D. dan, Wan, L., Wang, J. zhi, Zeng, Y., Shu, X. ji, Westermarck, J., Lu, Y. ming, Ohlmeyer, M., & Liu, R. (2020). Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer\u2019s Disease Pathogenesis in Cell and Animal Models. Neurotherapeutics, 17(3), 1087\u20131103. DOI: 10.1007\/s13311-020-00841-6.","DOI":"10.1007\/s13311-020-00841-6"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2275(20)42621-5","article-title":"Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112","volume":"31","author":"Weisgraber","year":"1990","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0940","doi-asserted-by":"crossref","unstructured":"Wu, L., Rosa-Neto, P., Hsiung, G. Y. R., Sadovnick, A. D., Masellis, M., Black, S. E., Jia, J., & Gauthier, S. (2012). Early-onset familial alzheimer\u2019s disease (EOFAD). Canad. J. Neurol. Sci. (Vol. 39, Issue 4, pp. 436\u2013445). Canadian Journal of Neurological Sciences. DOI: 10.1017\/S0317167100013949.","DOI":"10.1017\/S0317167100013949"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0945","doi-asserted-by":"crossref","unstructured":"Xia, Q., Yang, X. Y., Shi, J. Bin, Liu, Z. J., Peng, Y. H., Wang, W. J., Li, B. W., Zhao, Y., Xiao, J. Y., Huang, L., Wang, D. Y., & Gao, X. (2021). The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer\u2019s Disease. Mol. Neurobiol. (Vol. 58, Issue 8, pp. 4038\u20134050). Springer. DOI: 10.1007\/s12035-021-02385-y.","DOI":"10.1007\/s12035-021-02385-y"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0950","doi-asserted-by":"crossref","unstructured":"Xu, W., Tan, L., & Yu, J. T. (2015). The Role of PICALM in Alzheimer\u2019s Disease. Molecul. Neurobiol. (Vol. 52, Issue 1, pp. 399\u2013413). Humana Press Inc. DOI: 10.1007\/s12035-014-8878-3.","DOI":"10.1007\/s12035-014-8878-3"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0955","doi-asserted-by":"crossref","DOI":"10.1038\/s44328-025-00028-z","article-title":"Mechanism of amyloid fibril formation triggered by breakdown of supersaturation","volume":"2","author":"Yamaguchi","year":"2025","journal-title":"Npj Biosensing"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0960","doi-asserted-by":"crossref","unstructured":"Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C. C., & Bu, G. (2019). Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurol. (Vol. 15, Issue 9, pp. 501\u2013518). Nature Publishing Group. DOI: 10.1038\/s41582-019-0228-7.","DOI":"10.1038\/s41582-019-0228-7"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.10.050_b0965","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1093\/brain\/awu278","article-title":"Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: Prevention by correcting lysosomal proteolytic deficits","volume":"137","author":"Yang","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0970","doi-asserted-by":"crossref","unstructured":"Ye, H., Han, Y., Li, P., Su, Z., & Huang, Y. (2022). The Role of Post-Translational Modifications on the Structure and Function of Tau Protein. J. Molecul. Neurosci. (Vol. 72, Issue 8, pp. 1557\u20131571). Springer. DOI: 10.1007\/s12031-022-02002-0.","DOI":"10.1007\/s12031-022-02002-0"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0975","doi-asserted-by":"crossref","unstructured":"Yi, L. X., Zeng, L., Wang, Q., Tan, E. K., & Zhou, Z. D. (2024). Reelin links Apolipoprotein E4, Tau, and Amyloid-\u03b2 in Alzheimer\u2019s disease. Age. Res. Rev. (Vol. 98). Elsevier Ireland Ltd. DOI: 10.1016\/j.arr.2024.102339.","DOI":"10.1016\/j.arr.2024.102339"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.050_b0980","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1080\/21655979.2021.2024323","article-title":"Zebularine protects against blood-brain-barrier (BBB) disruption through increasing the expression of zona occludens-1 (ZO-1) and vascular endothelial (VE)-cadherin","volume":"13","author":"Zeng","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0985","doi-asserted-by":"crossref","unstructured":"Zhang, W., Xu, C., Sun, J., Shen, H. M., Wang, J., & Yang, C. (2022). Impairment of the autophagy\u2013lysosomal pathway in Alzheimer\u2019s diseases: Pathogenic mechanisms and therapeutic potential. Acta Pharmaceut. Sin. B (Vol. 12, Issue 3, pp. 1019\u20131040). Chinese Academy of Medical Sciences. DOI: 10.1016\/j.apsb.2022.01.008.","DOI":"10.1016\/j.apsb.2022.01.008"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0995","doi-asserted-by":"crossref","unstructured":"Zhou, Z., Shi, B., Xu, Y., Zhang, J., liu, X., Zhou, X., Feng, B., Ma, J., & Cui, H. (2023). Neural stem\/progenitor cell therapy for Alzheimer disease in preclinical rodent models: a systematic review and meta-analysis. Stem Cell Res. Ther. (Vol. 14, Issue 1). BioMed Central Ltd. DOI: 10.1186\/s13287-022-03231-1.","DOI":"10.1186\/s13287-022-03231-1"},{"key":"10.1016\/j.neuroscience.2025.10.050_b1000","doi-asserted-by":"crossref","unstructured":"Zhu, X. C., Yu, J. T., Jiang, T., Wang, P., Cao, L., & Tan, L. (2015). CR1 in Alzheimer\u2019s Disease. Molecul. Neurobiol. (Vol. 51, Issue 2, pp. 753\u2013765). Humana Press Inc. DOI: 10.1007\/s12035-014-8723-8.","DOI":"10.1007\/s12035-014-8723-8"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b1005","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12684","article-title":"Amyloid Beta monomers regulate cyclic adenosine monophosphate response element binding protein functions by activating type-1 insulin-like growth factor receptors in neuronal cells","volume":"17","author":"Zimbone","year":"2018","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b1010","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-50153-y","article-title":"\u03b2-amyloid monomer scavenging by an anticalin protein prevents neuronal hyperactivity in mouse models of Alzheimer\u2019s Disease","volume":"15","author":"Zott","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2025.10.050_b1015","doi-asserted-by":"crossref","unstructured":"\u017bukowska, J., Moss, S. J., Subramanian, V., & Acharya, K. R. (2024). Molecular basis of selective amyloid-\u03b2 degrading enzymes in Alzheimer\u2019s disease. FEBS J. (Vol. 291, Issue 14, pp. 2999\u20133029). John Wiley and Sons Inc. DOI: 10.1111\/febs.16939.","DOI":"10.1111\/febs.16939"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0035","doi-asserted-by":"crossref","unstructured":"Alavi Naini, S. M., & Soussi-Yanicostas, N. (2015). Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies? In Oxidative Medicine and Cellular Longevity (Vol. 2015). Hindawi Limited. DOI: 10.1155\/2015\/151979.","DOI":"10.1155\/2015\/151979"},{"issue":"10","key":"10.1016\/j.neuroscience.2025.10.050_b0100","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCRESAHA.116.309686","article-title":"Loss of Endothelial Nitric Oxide Synthase Promotes p25 Generation and Tau Phosphorylation in a Murine Model of Alzheimer\u2019s Disease","volume":"119","author":"Austin","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0155","doi-asserted-by":"crossref","unstructured":"Calvo-Rodriguez, M., & Bacskai, B. J. (2021). Mitochondria and Calcium in Alzheimer\u2019s Disease: From Cell Signaling to Neuronal Cell Death. Trend. Neurosci. (Vol. 44, Issue 2, pp. 136\u2013151). Elsevier Ltd. DOI: 10.1016\/j.tins.2020.10.004.","DOI":"10.1016\/j.tins.2020.10.004"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0165","doi-asserted-by":"crossref","unstructured":"Canepa, E., & Fossati, S. (2021). Impact of Tau on Neurovascular Pathology in Alzheimer\u2019s Disease. Front. Neurol. (Vol. 11). Frontiers Media S.A. DOI: 10.3389\/fneur.2020.573324.","DOI":"10.3389\/fneur.2020.573324"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0225","doi-asserted-by":"crossref","unstructured":"Congdon, E. E., & Sigurdsson, E. M. (2018). Tau-targeting therapies for Alzheimer disease. Nat. Rev. Neurology (Vol. 14, Issue 7, pp. 399\u2013415). Nature Publishing Group. DOI: 10.1038\/s41582-018-0013-z.","DOI":"10.1038\/s41582-018-0013-z"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0230","doi-asserted-by":"crossref","unstructured":"Cummings, J. L., & Cole, G. (2002). Alzheimer Disease (JAMA Network, Ed.; Vol. 287, pp. 2335\u20132338). http:\/\/jama.jamanetwork.com\/.","DOI":"10.1001\/jama.287.18.2335"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.10.050_b0245","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3233\/JAD-160953","article-title":"Localization and processing of the amyloid-\u03b2 protein precursor in mitochondria-associated membranes","volume":"55","author":"Del Prete","year":"2017","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0300","doi-asserted-by":"crossref","unstructured":"Flowers, S. A., & Rebeck, G. W. (2020). APOE in the normal brain. Neurobiol. Dis. (Vol. 136). Academic Press Inc. Doi: 10.1016\/j.nbd.2019.104724.","DOI":"10.1016\/j.nbd.2019.104724"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0315","doi-asserted-by":"crossref","unstructured":"Fu, W. Y., & Ip, N. Y. (2023). The role of genetic risk factors of Alzheimer\u2019s disease in synaptic dysfunction. Semin. Cell Develop. Biol. (Vol. 139, pp. 3\u201312). Elsevier Ltd. DOI: 10.1016\/j.semcdb.2022.07.011.","DOI":"10.1016\/j.semcdb.2022.07.011"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0335","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s13311-020-00954-y","article-title":"Iron and ferroptosis as therapeutic targets in Alzheimer\u2019s disease","volume":"18","author":"Gleason","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"13","key":"10.1016\/j.neuroscience.2025.10.050_b0340","doi-asserted-by":"crossref","DOI":"10.1002\/j.1460-2075.1990.tb07870.x","article-title":"Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization","volume":"9","author":"Goedert","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0365","doi-asserted-by":"crossref","unstructured":"Hadi Alijanvand, S., Peduzzo, A., & Buell, A. K. (2021). Secondary Nucleation and the Conservation of Structural Characteristics of Amyloid Fibril Strains. Front. Molecul. Biosci. (Vol. 8). Frontiers Media S.A. DOI: 10.3389\/fmolb.2021.669994.","DOI":"10.3389\/fmolb.2021.669994"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0400","doi-asserted-by":"crossref","unstructured":"Huang, Y., & Mahley, R. W. (2014). Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases. Neurobiol. Dis. (Vol. 72, Issue Part A, pp. 3\u201312). Academic Press Inc. DOI: 10.1016\/j.nbd.2014.08.025.","DOI":"10.1016\/j.nbd.2014.08.025"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0410","doi-asserted-by":"crossref","unstructured":"Huynh, T. P. V., & Holtzman, D. M. (2018). In Search of an Identity for Amyloid Plaques. Trend. Neurosci. (Vol. 41, Issue 8, pp. 483\u2013486). Elsevier Ltd. DOI: 10.1016\/j.tins.2018.06.002.","DOI":"10.1016\/j.tins.2018.06.002"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0440","doi-asserted-by":"crossref","unstructured":"Kahlson, M. A., & Colodner, K. J. (2015). Glial tau pathology in tauopathies: Functional consequences. J. Exp. Neurosci. (Vol. 9s2, pp. 43\u201350). SAGE Publications Ltd. DOI: 10.4137\/JEN.S25515.","DOI":"10.4137\/JEN.S25515"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0460","doi-asserted-by":"crossref","unstructured":"Karch, C. M., & Goate, A. M. (2015). Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol. Psych. (Vol. 77, Issue 1, pp. 43\u201351). Elsevier USA. Doi: 10.1016\/j.biopsych.2014.05.006.","DOI":"10.1016\/j.biopsych.2014.05.006"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0560","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00203","article-title":"Targeting autophagy for the treatment of Alzheimer\u2019s disease: challenges and opportunities","volume":"12","author":"Liu","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.10.050_b0570","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pathophys.2009.02.008","article-title":"Protein phosphatase 2A in Alzheimer\u2019s disease","volume":"16","author":"Liu","year":"2009","journal-title":"Pathophysiology"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.10.050_b0625","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41591-019-0375-9","article-title":"Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer\u2019s disease","volume":"25","author":"Moreno-Jim\u00e9nez","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0001","doi-asserted-by":"crossref","unstructured":"Mendes, A.J., Ribaldi, F., Pievani, M., Boccalini, C., Garibotto, V., Frisoni, G.B. and Alzheimer's Disease Neuroimaging Initiative, 2025. Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease. Neurology, 104(11), p.e213675.","DOI":"10.1212\/WNL.0000000000213675"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.050_b0760","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40142-014-0034-x","article-title":"Late-Onset Alzheimer\u2019s Disease Genes and the Potentially Implicated Pathways","volume":"2","author":"Rosenthal","year":"2014","journal-title":"Curr. Genet. Med. Rep."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.10.050_b0795","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.10.050_b0810","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn3156","article-title":"Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration","volume":"13","author":"Sheng","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.10.050_b0860","doi-asserted-by":"crossref","unstructured":"Tharp, W. G., & Sarkar, I. N. (2013). Origins of amyloid-\u03b2. http:\/\/www.biomedcentral.com\/1471-2164\/14\/290.","DOI":"10.1186\/1471-2164-14-290"},{"key":"10.1016\/j.neuroscience.2025.10.050_b0870","unstructured":"Thromb, A., & Biol, V. (2016). Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism. http:\/\/ahajournals.org."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.10.050_b0990","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-1-5","article-title":"The amyloid precursor protein: beyond amyloid","volume":"1","author":"Zheng","year":"2006","journal-title":"Mol. Neurodegener."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225010486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225010486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T21:37:19Z","timestamp":1764884239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225010486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":203,"alternative-id":["S0306452225010486"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.10.050","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tangles and Plaques: A deep dive into the pathological hallmarks of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.10.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}